Annals of Hepatology

Updated recommendations for the management of metabolic dysfunction¿associated steatotic liver disease (MASLD) by the Latin American working group Luis Antonio Diaz; Juan Pablo Arab; Francisco Idalsoaga; Javiera Perelli; Javier Vega; Melisa Dirchwolf; Javiera Carreño; Bárbara Samith; Cynthia Valério; Rodrigo Oliveira Moreira; Mónica Acevedo; Javier Brahm; Nelia Hernández; Adrian Gadano; Claudia P. Oliveira; Marco Arrese; Graciela Castro-Narro; Mario G. Pessoa;

Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD ¿ a prospective interventional study Adam Va¿ura; Ev¿en Machytka; Ond¿ej Urban; Jitka Machá¿ková; Lubomír Pavliska; Zden¿k Berka; Zden¿k ¿vagera; Marek Bu¿ga;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;